Cargando…
Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study
BACKGROUND: Although a recent study reported that fibrates are associated with a low risk of cardiovascular (CV) death and can postpone the need for long-term hemodialysis in patients with advanced chronic kidney disease (CKD), little is known regarding whether the CV protective effects of fibrates...
Autores principales: | Ho, Wen-Yu, Yen, Chieh-Li, Lee, Cheng-Chia, Tu, Yi-Ran, Chen, Chao-Yu, Hsiao, Ching-Chung, Chu, Pao-Hsien, Hsu, Hsiang-Hao, Tian, Ya-Chun, Chang, Chih-Hsiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681823/ https://www.ncbi.nlm.nih.gov/pubmed/36440016 http://dx.doi.org/10.3389/fcvm.2022.907539 |
Ejemplares similares
-
Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease
por: Yen, Chieh‐Li, et al.
Publicado: (2022) -
Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction and Advanced Chronic Kidney Disease: A Retrospective Multi-Institutional Study
por: Hsiao, Fu-Chih, et al.
Publicado: (2022) -
SUN-071 Unexpected Paradoxical Extremely Low of HDL-Cholesterol Level in a Non-Diabetes, Non-CKD Patient after Treatment with Specific Fibrate and Statin and Specific Fibrate Alone
por: Kiatpanabhikul, Phatharaporn
Publicado: (2019) -
Supplementation with Folic Acid and Cardiovascular Outcomes in End-Stage Kidney Disease: A Multi-Institution Cohort Study
por: Tu, Yi-Ran, et al.
Publicado: (2022) -
Fibrates consistently lower risk of cardiovascular events across high-risk groups
por: Aalbers, J
Publicado: (2010)